Pancreatic Cancer Research

ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Tiago De Oliveira

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2502-7897; OpenAlex author ID A5065099160. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117649↗
  2. Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12943-026-02628-3↗
  3. KRAS G 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening. Co-author DOI 10.1002/1878-0261.13725↗
  4. The actin binding protein destrin is associated with growth and perineural invasion of pancreatic cancer. Co-author DOI 10.1016/j.pan.2012.05.012↗
  5. Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype. Co-author DOI 10.1186/1476-4598-11-19↗
  6. Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling. Co-author DOI 10.1002/ijc.25898↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lena‐Christin Conradi · 3 shared papers, 2025–2026 · strength 0.58
  2. Argyris Papantonis · 2 shared papers, 2026 · strength 0.41
  3. Gabriela Salinas · 2 shared papers, 2025–2026 · strength 0.39
  4. Michael B. Ghadimi · 2 shared papers, 2025–2026 · strength 0.36
  5. Ulrich Sax · 2 shared papers, 2025–2026 · strength 0.36
  6. Carolin Schneider · 2 shared papers, 2025–2026 · strength 0.36
  7. Günter Schneider · 2 shared papers, 2025–2026 · strength 0.36
  8. Elisabeth Heßmann · 2 shared papers, 2025–2026 · strength 0.36
  9. Adi Danieli‐Mackay · 1 shared paper, 2026 · strength 0.22
  10. Emre Taylan Duman · 1 shared paper, 2026 · strength 0.22
  11. Shiv K. Singh · 1 shared paper, 2026 · strength 0.22
  12. Lukas Klein · 1 shared paper, 2026 · strength 0.22
  13. Matthias Dobbelstein · 1 shared paper, 2026 · strength 0.22
  14. Alexandra Maria Schmitt · 1 shared paper, 2026 · strength 0.19
  15. Nathalia Luisa Carlos Ferreira · 1 shared paper, 2026 · strength 0.19
  16. Christian Schneeweis · 1 shared paper, 2025 · strength 0.17
  17. Marian Grade · 1 shared paper, 2025 · strength 0.17
  18. Jonas Hügel · 1 shared paper, 2025 · strength 0.17
  19. Jochen Gaedcke · 1 shared paper, 2025 · strength 0.17
  20. Maximilian Reichert · 1 shared paper, 2025 · strength 0.17
  21. Lukas Krauß · 1 shared paper, 2025 · strength 0.17
  22. Constanza Tapia Contreras · 1 shared paper, 2025 · strength 0.17
  23. Matthias Wirth · 1 shared paper, 2025 · strength 0.17
  24. Volker Ellenrieder · 1 shared paper, 2025 · strength 0.17
  25. Dieter Saur · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.